Intra-cranial administration of CTLA-4 and PD-1 immune checkpoint-inhibiting monoclonal antibodies in recurrent glioblastoma patients: a multi-cohort adaptive phase I clinical trial

Onderzoeksoutput: Poster

Originele taal-2English
StatusPublished - 2021
Evenement26th Annual Meeting and Education Day of the Society for Neuro-Oncology
- Boston, United States
Duur: 18 nov 202121 nov 2021

Conference

Conference26th Annual Meeting and Education Day of the Society for Neuro-Oncology
LandUnited States
StadBoston
Periode18/11/2121/11/21

Citeer dit